Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 1551-1554, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, N.
Right arrow Articles by Tokuda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, N.
Right arrow Articles by Tokuda, K.

Clinical Chemistry, Vol 32, 1551-1554, Copyright © 1986 by American Association for Clinical Chemistry

Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer

N Watanabe, S Kamei, A Ohkubo, M Yamanaka, S Ohsawa, K Makino and K Tokuda

In this new method for determining urinary protein, the reaction is complete within 10 min at 37 degrees C. This method is applicable to automated as well as manual measurements. Protein concentration and absorbance at 600 nm are linearly related throughout a wide range of concentrations, 10 to 16 000 mg/L. However, the chromogenicity of the gamma-globulins in this method is 70% of that of albumin, as estimated from results by a biuret method. Within-run CVs were less than 3.3%; the day-to-day CV was 2.9%. Errors due to interfering components in urine are less than 2%. The normal range for urinary protein as measured by this method was from 28 to 141 mg/day. Results by this method (y) and by a trichloroacetic acid-biuret method (x) correlated well (n = 80, r = 0.995; y = 0.99x - 2.9).


The following articles in journals at HighWire Press have cited this article:


Home page
 CJASNHome page
D. J. Birmingham, B. H. Rovin, G. Shidham, M. Bissell, H. N. Nagaraja, and L. A. Hebert
Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus Nephritis: Diagnostic and Therapeutic Implications
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1028 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
U. Benck, S. Haeckel, J. H. Clorius, and F. J. van der Woude
Proteinuria-Lowering Effect of Heparin Therapy in Diabetic Nephropathy without Affecting the Renin-Angiotensin-Aldosterone System
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 58 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Takakura, A. Takimoto, Y. Notsu, H. Yoshida, T. Ito, H. Nagatome, M. Ohno, Y. Kobayashi, T. Yoshioka, K. Inagaki, et al.
Physicochemical and Pharmacokinetic Characterization of Highly Potent Recombinant L-Methionine {gamma}-Lyase Conjugated with Polyethylene Glycol as an Antitumor Agent.
Cancer Res., March 1, 2006; 66(5): 2807 - 2814.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Seagrave, A. Gigliotti, J. D. McDonald, S. K. Seilkop, K. A. Whitney, B. Zielinska, and J. L. Mauderly
Composition, Toxicity, and Mutagenicity of Particulate and Semivolatile Emissions from Heavy-Duty Compressed Natural Gas-Powered Vehicles
Toxicol. Sci., September 1, 2005; 87(1): 232 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Herzum, H. Renz, and H. G. Wahl
Immunochemical Quantification of Free Light Chains in Urine
Clin. Chem., June 1, 2005; 51(6): 1033 - 1035.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. Ofstad and B. M. Iversen
Glomerular and tubular damage in normotensive and hypertensive rats
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F665 - F672.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Maachi, S. Fellahi, A. Regeniter, M.-E. Diop, J. Capeau, J. Rossert, and J.-P. Bastard
Patterns of Proteinuria: Urinary Sodium Dodecyl Sulfate Electrophoresis Versus Immunonephelometric Protein Marker Measurement Followed by Interpretation with the Knowledge-Based System MDI-LabLink
Clin. Chem., October 1, 2004; 50(10): 1834 - 1837.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Elimination of the Interference from Aminoglycoside Antibiotics in the Pyrogallol Red-Molybdate Protein Dye-Binding Assay
Clin. Chem., September 1, 2004; 50(9): 1674 - 1675.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Yang, X. Sun, S. Li, Y. Tan, X. Wang, N. Zhang, S. Yagi, T. Takakura, Y. Kobayashi, A. Takimoto, et al.
Circulating Half-Life of PEGylated Recombinant Methioninase Holoenzyme Is Highly Dose Dependent on Cofactor Pyridoxal-5'-Phosphate
Cancer Res., August 15, 2004; 64(16): 5775 - 5778.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. M. Yilmaz, N. Celebi, and D. Yucel
Automated Turbidimetric Benzalkonium Chloride Method for Measurement of Protein in Urine and Cerebrospinal Fluid
Clin. Chem., August 1, 2004; 50(8): 1450 - 1452.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. Oestvang, D. Bonnefont-Rousselot, E. Ninio, J. K. Hakala, B. Johansen, and M. W. Anthonsen
Modification of LDL with human secretory phospholipase A2 or sphingomyelinase promotes its arachidonic acid-releasing propensity
J. Lipid Res., May 1, 2004; 45(5): 831 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Extent of Aminoglycoside Interference in the Pyrogallol Red-Molybdate Protein Assay Depends on the Concentration of Sodium Oxalate in the Dye Reagent
Clin. Chem., May 1, 2004; 50(5): 934 - 935.
[Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
R. B. Caldwell and C. T. Lattemann
Simple and Reliable Method To Precipitate Proteins from Bacterial Culture Supernatant
Appl. Envir. Microbiol., January 1, 2004; 70(1): 610 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Sun, Z. Yang, S. Li, Y. Tan, N. Zhang, X. Wang, S. Yagi, T. Yoshioka, A. Takimoto, K. Mitsushima, et al.
In Vivo Efficacy of Recombinant Methioninase Is Enhanced by the Combination of Polyethylene Glycol Conjugation and Pyridoxal 5'-Phosphate Supplementation
Cancer Res., December 1, 2003; 63(23): 8377 - 8383.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Aminoglycoside Interference in the Pyrogallol Red-Molybdate Protein Assay Is Increased by the Addition of Sodium Dodecyl Sulfate to the Dye Reagent
Clin. Chem., December 1, 2003; 49(12): 2111 - 2112.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. R. Tate, D. Gill, R. Cobcroft, and P. E. Hickman
Practical Considerations for the Measurement of Free Light Chains in Serum
Clin. Chem., August 1, 2003; 49(8): 1252 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. Anim-Nyame, J. Gamble, S. R. Sooranna, M. R. Johnson, and P. J. Steer
Microvascular permeability is related to circulating levels of tumour necrosis factor-{alpha} in pre-eclampsia
Cardiovasc Res, April 1, 2003; 58(1): 162 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Total Protein Determination in Urine: Aminoglycoside Interference
Clin. Chem., January 1, 2003; 49(1): 202 - 203.
[Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Seagrave, J. D. McDonald, A. P. Gigliotti, K. J. Nikula, S. K. Seilkop, M. Gurevich, and J. L. Mauderly
Mutagenicity and in Vivo Toxicity of Combined Particulate and Semivolatile Organic Fractions of Gasoline and Diesel Engine Emissions
Toxicol. Sci., December 1, 2002; 70(2): 212 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Bertram, N. Blanc-Brunat, J. Sassard, and M. Lo
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1041 - R1045.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. E. Cogo, L. J. I. Zimmermann, F. Rosso, F. Tormena, P. Gamba, G. Verlato, A. Baritussio, and V. P. Carnielli
Surfactant Synthesis and Kinetics in Infants with Congenital Diaphragmatic Hernia
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 154 - 158.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
D. Creamer, M. Allen, R. Jaggar, R. Stevens, R. Bicknell, and J. Barker
Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor
Arch Dermatol, June 1, 2002; 138(6): 791 - 796.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. Chelliah, G. A. Sagnella, N. D. Markandu, and G. A. MacGregor
Urinary Protein and Essential Hypertension in Black and in White People
Hypertension, June 1, 2002; 39(6): 1064 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Ogita, H. Okuda, M. Kitano, Y. Fujinami, K. Ozaki, and Y. Yoneda
Localization of Activator Protein-1 Complex with DNA Binding Activity in Mitochondria of Murine Brain after In Vivo Treatment with Kainate
J. Neurosci., April 1, 2002; 22(7): 2561 - 2570.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Bonnefont-Rousselot, E. Lehmann, M.-C. Jaudon, J. Delattre, B. Perrone, and J.-P. Rechke
Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane
Nephrol. Dial. Transplant., December 1, 2000; 15(12): 2020 - 2028.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
S. MURAKAMI, M. SAITOH, T. KUBO, T. KOYAMA, and M. KOBAYASHI
Renal Disease in Women With Severe Preeclampsia or Gestational Proteinuria
Obstet. Gynecol., December 1, 2000; 96(6): 945 - 949.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. F. McGinnity, A. J. Parker, M. Soars, and R. J. Riley
Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s
Drug Metab. Dispos., November 1, 2000; 28(11): 1327 - 1334.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
M. SHIOZAWA, A. P. PROVOOST, R. P. E. V. DOKKUM, R. R. MAJEWSKI, and H. J. JACOB
Evidence of Gene--Gene Interactions in the Genetic Susceptibility to Renal Impairment after Unilateral Nephrectomy
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2068 - 2078.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
T. Marshall and K. M. Williams
Total Protein Determination in Urine: Elimination of a Differential Response between the Coomassie Blue and Pyrogallol Red Protein Dye-binding Assays
Clin. Chem., March 1, 2000; 46(3): 392 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Biou, J.-F. Benoist, C. Nguyen-Thi, X. Huong, P. Morel, and M. Marchand
Cerebrospinal Fluid Protein Concentrations in Children: Age-related Values in Patients without Disorders of the Central Nervous System
Clin. Chem., March 1, 2000; 46(3): 399 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. F. McGinnity, S. J. Griffin, G. C. Moody, M. Voice, S. Hanlon, T. Friedberg, and R. J. Riley
Rapid Characterization of the Major Drug-Metabolizing Human Hepatic Cytochrome P-450 Enzymes Expressed in Escherichia coli
Drug Metab. Dispos., September 1, 1999; 27(9): 1017 - 1023.
[Abstract] [Full Text]

Home page
 Ann Rheum DisHome page
B. P C Hazenberg, P. C Limburg, J. Bijzet, and M. H van Rijswijk
A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis
Ann Rheum Dis, February 1, 1999; 58(2): 96 - 102.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
M. Hemmelder, D. de Zeeuw, and P. de Jong
Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 98 - 104.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
T. Le Bricon, D. Erlich, D. Bengoufa, M. Dussaucy, J.-P. Garnier, and B. Bousquet
Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma
Clin. Chem., June 1, 1998; 44(6): 1191 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Pena, C. Martinez-Bru, R. Homs, T. Planella, and M. Cortes
Effect of Plasma Replacement Therapy on Determinations of Urine Protein Concentration
Clin. Chem., February 1, 1998; 44(2): 359 - 360.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Siegenthaler, K. Roulin, D. Chatellard-Gruaz, R. Hotz, J. H. Saurat, U. Hellman, and G. Hagens
A Heterocomplex Formed by the Calcium-binding Proteins MRP8 (S100A8) and MRP14 (S100A9) Binds Unsaturated Fatty Acids with High Affinity
J. Biol. Chem., April 4, 1997; 272(14): 9371 - 9377.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
A. P. Provoost, M. Shiozawa, R. P. E. Van Dokkum, and H. J. Jacob
Transfer of the Rf-1 region from FHH onto the ACI background increases susceptibility to renal impairment
Physiol Genomics, February 28, 2002; 8(2): 123 - 129.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.